← Leaderboards
Roberto Chiarle
Boston Children'S Hospital
$6,079,956
Attributed
$6,079,956
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $825.3K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,079,956 · 2
By mechanism
R01$6,079,956 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationCellsGenerationsSignal TransductionBiologyIn VivoMouse ModelMolecularResponseBaseDown-RegulationExperimental StudyIn VitroAnaplastic Lymphoma KinaseIn Vivo ModelCandidate Disease GeneChromosomal TranslocationKinase InhibitorFutureKi-1 Large-Cell LymphomaFamilyModalityGenetic ScreeningLymphoma
Grant awards (15)
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma$420,375
R01 · FY2025 · CA · contact PI
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma$399,356
R01 · FY2024 · CA · contact PI
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma$411,968
R01 · FY2023 · CA · contact PI
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma$411,968
R01 · FY2022 · CA · contact PI
APOBEC proteins as drivers of chromosomal translocations in solid cancers$396,790
R01 · FY2022 · CA · contact PI
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma$420,375
R01 · FY2021 · CA · contact PI
APOBEC proteins as drivers of chromosomal translocations in solid cancers$404,888
R01 · FY2021 · CA · contact PI
APOBEC proteins as drivers of chromosomal translocations in solid cancers$404,888
R01 · FY2020 · CA · contact PI
APOBEC proteins as drivers of chromosomal translocations in solid cancers$392,740
R01 · FY2019 · CA · contact PI
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma$392,740
R01 · FY2019 · CA · contact PI
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma$404,888
R01 · FY2018 · CA · contact PI
APOBEC proteins as drivers of chromosomal translocations in solid cancers$404,888
R01 · FY2018 · CA · contact PI
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma$404,888
R01 · FY2017 · CA · contact PI
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma$404,888
R01 · FY2016 · CA · contact PI
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma$404,316
R01 · FY2015 · CA · contact PI